Original Research ArticleInternational Journal of Pharmaceutical InvestigationVol. 7 | Issue 2 | pp. 101–106Open access
Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
- 1,
- 2,
- 2,
- 1*
- 1 Department of Periodontology, Faculty of Dental Sciences, Sri Ramachandra University, INDIA.
- 2 Department of Pharmaceutics, Faculty of Pharmacy, Sri Ramachandra University, Chennai, Tamil Nadu, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Suresh Ranga Rao
Department of Periodontology, Faculty of Dental Sciences, Sri Ramachandra University, INDIA.
Email: chennaidentist@gmail.com
- DOI:
- 10.4103/jphi.JPHI_26_17
How to cite
Rajendran, S., Kumar, K. S., Ramesh, S., & Rao, S. R. Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease. International Journal of Pharmaceutical Investigation, 7(2), 101–106. https://doi.org/10.4103/jphi.JPHI_26_17
Abstract
Objective: The aim of this in vitro study was to formulate an in situ thermoreversible injectable gel with poloxamer (PM) and methylcellulose (MC) to deliver simvastatin (SMV) in a controlled manner. Subjects and Methods: Preformulation studies (Fourier transform infrared and differential scanning calorimetry) to assess the interaction between SMV and MC and PM were performed before gel formulation. Keeping the concentration of SMV at 2.2%, the concentration of PM and MC was altered to formulate in situ thermosensitive gel at 37°C. Rheological studies were carried to analyze the physical property of the various formulations. Drug release profile and stability studies were done for the selected formulation. The in vitro drug release profile was carried out for using open end tube method and ultraviolet spectroscopy. Results: The preformulation studies showed that there is no interaction between the polymer and drug based on the rheological studies of different formulation, the formulation. F8 gels at 37°C and attains a viscosity of 4150 cps. Conclusions: PM 25% and MC 5% formed an ideal thermosensitive injectable gel at 37°C for subgingival delivery of SMV and also show controlled drug release for the period of 10 days in vitro.
Keywords
Subject
Article metadata
| Title | Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease |
|---|---|
| Authors | Swaminathan Rajendran; K. Sathesh Kumar; S Ramesh; Suresh Ranga Rao |
| Affiliations | Department of Periodontology, Faculty of Dental Sciences, Sri Ramachandra University, INDIA.; Department of Pharmaceutics, Faculty of Pharmacy, Sri Ramachandra University, Chennai, Tamil Nadu, INDIA. |
| Corresponding author | chennaidentist@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 7, Issue 2 |
Also in this issue
- Compensation to clinical trial participants in India: A gap analysispp. 41–46
- Application of three‑dimensional printing for colon targeted drug delivery systemspp. 47–59
- Determining frequency of genes of CTX‑M and CTX‑M‑15 of producing Enterobacteriaceae of isolated extended‑spectrum beta‑lactamases from clinical samples of patients referred to training hospitals of Medical Sciences University, Khorramabad, Iranpp. 60–69
- Brand versus generic dispensing trend for ciprofloxacin 500 mg, levofloxacin 500 mg, and moxifloxacin 400 mg (oral dosage forms) among pharmacies of Karachi, Pakistanpp. 70–76
- Antifungal effects of Lactobacillus species isolated from local dairy productspp. 77–81